Lindbrook Capital’s Zai Lab ZLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-503
Closed -$32K 2634
2021
Q4
$32K Buy
503
+185
+58% +$15.7K ﹤0.01% 873
2021
Q3
$34K Buy
318
+9
+3% +$1.29K 0.01% 563
2021
Q2
$55K Buy
309
+38
+14% +$6.11K 0.01% 447
2021
Q1
$36K Buy
271
+12
+5% +$1.86K 0.01% 555
2020
Q4
$35K Buy
259
+79
+44% +$8.04K 0.01% 515
2020
Q3
$15K Sell
180
-35
-16% -$2.81K ﹤0.01% 722
2020
Q2
$18K Buy
215
+54
+34% +$3.65K 0.01% 653
2020
Q1
$8K Buy
161
+13
+9% +$678 ﹤0.01% 843
2019
Q4
$6K Hold
148
﹤0.01% 1077
2019
Q3
$5K Hold
148
﹤0.01% 1084
2019
Q2
$5K Hold
148
﹤0.01% 1073
2019
Q1
$4K Buy
+148
New +$4.05K ﹤0.01% 1144

Other funds holding ZLAB

Lindbrook Capital's ZLAB Position: Q1 2022 in Review

Lindbrook Capital sold out of Zai Lab (ZLAB) in Q1 2022, closing a stake of 503 shares — an estimated $32K sold.

Lindbrook Capital first reported a position in ZLAB in Q1 2019 and held it in 12 quarters. The position peaked at $55K in Q2 2021. 175 funds tracked by Wall St. Rank hold ZLAB as of Q1 2022.

  • Lindbrook Capital reported no remaining Zai Lab position as of Q1 2022 after selling out during the quarter.
  • Lindbrook Capital sold 503 Zai Lab shares in Q1 2022, an estimated $32K.
  • Lindbrook Capital first reported a position in Zai Lab in Q1 2019 and held it in 12 quarters.
  • Lindbrook Capital's Zai Lab position peaked at $55K in Q2 2021.
  • 175 funds tracked by Wall St. Rank held Zai Lab as of Q1 2022.

Based on Lindbrook Capital's 13F filing for Q1 2022, filed 21 Apr 2022.